⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15156812 | 0.77 | — | — | |
| SCHEMBL23296833 | 0.70 | — | — | |
| SCHEMBL23924792 | 0.69 | — | — | |
| SCHEMBL8990250 | 0.67 | — | — | |
| SCHEMBL15936851 | 0.65 | SPHK1 (0.35) | — | |
| SCHEMBL15157131 | 0.65 | SPHK1 (0.35) | — | |
| SCHEMBL7823469 | 0.65 | — | — | |
| SCHEMBL8895562 | 0.59 | MAPK1 (0.41) | — | |
| SCHEMBL5795974 | 0.57 | MAPK1 (0.36) | — | |
| SCHEMBL4411311 | 0.57 | MAPK1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9758525-B2 | Spiro-lactam NMDA receptor modulators and uses thereof | APTINYX INC. (US) | 2017-09-12 | — | — | US | disclosed |
| US-20150368253-A1 | SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF | TENACIA BIOTECHNOLOGY (HONG KONG) CO., LIMITED (HK) | 2015-12-24 | — | — | US | disclosed |